Attività
Numero di dipendenti: 53
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 11/10/18 |
Frank Lanza
DFI | Director of Finance/CFO | 62 | 01/04/19 |
Chatan Charan
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/22 |
Holger Wesche
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/10/18 |
Luke Walker
CTO | Chief Tech/Sci/R&D Officer | - | 03/10/22 |
Haibo Wang
PRN | Corporate Officer/Principal | - | 01/08/23 |
Banmeet Anand
PRN | Corporate Officer/Principal | - | 06/07/22 |
Wendy Chang
HRO | Human Resources Officer | - | 06/07/22 |
Rachael Lester
PRN | Corporate Officer/Principal | - | 01/09/17 |
James B. Bucher
LAW | General Counsel | 59 | 26/12 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 11/10/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 21 397 205 | 16 465 638 ( 76,95 %) | 0 | 76,95 % |
Coordinate società
Harpoon Therapeutics, Inc.
611 Gateway Boulevard Suite 400
94080, South San Francisco
+650 443 7400
http://www.harpoontx.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
-3,12% | 102 Mrd | |
+1,63% | 96,29 Mrd | |
+2,13% | 22,18 Mrd | |
-15,45% | 21,2 Mrd | |
-9,21% | 18,31 Mrd | |
-39,98% | 17,38 Mrd | |
-15,70% | 16,36 Mrd | |
+5,33% | 13,97 Mrd | |
+32,45% | 12,17 Mrd |